{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:43:07Z","timestamp":1792788187711,"version":"4.5.0"},"reference-count":138,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T00:00:00Z","timestamp":1737676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T00:00:00Z","timestamp":1737676800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82203377"],"award-info":[{"award-number":["82203377"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82473238"],"award-info":[{"award-number":["82473238"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Zhejiang natural science foundation of China","award":["LQ22H160036"],"award-info":[{"award-number":["LQ22H160036"]}]},{"name":"Zhejiang natural science foundation of China","award":["LY24H160022"],"award-info":[{"award-number":["LY24H160022"]}]},{"name":"Research Center for Lung Tumor Diagnosis and Treatment of Zhejiang Province","award":["JBZX-202007"],"award-info":[{"award-number":["JBZX-202007"]}]},{"name":"Zhejiang Health Science and Technology Project","award":["2025KY031"],"award-info":[{"award-number":["2025KY031"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Commun Signal"],"DOI":"10.1186\/s12964-024-02018-6","type":"journal-article","created":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T00:11:16Z","timestamp":1737677476000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":99,"title":["Glutamine and cancer: metabolism, immune microenvironment, and therapeutic targets"],"prefix":"10.1186","volume":"23","author":[{"given":"Ding","family":"Nan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiping","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luanluan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiqi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjie","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hailong","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haibo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodong","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanwei","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,24]]},"reference":[{"issue":"6","key":"2018_CR1","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.tem.2019.03.003","volume":"30","author":"E Bernfeld","year":"2019","unstructured":"Bernfeld E, Foster DA. Glutamine as an Essential Amino Acid for KRas-Driven Cancer Cells. Trends Endocrinol Metab. 2019;30(6):357\u201368. https:\/\/doi.org\/10.1016\/j.tem.2019.03.003.","journal-title":"Trends Endocrinol Metab"},{"issue":"9","key":"2018_CR2","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1038\/s12276-020-00504-8","volume":"52","author":"HC Yoo","year":"2020","unstructured":"Yoo HC, Yu YC, Sung Y, Han JM. Glutamine reliance in cell metabolism. Exp Mol Med. 2020;52(9):1496\u2013516. https:\/\/doi.org\/10.1038\/s12276-020-00504-8.","journal-title":"Exp Mol Med"},{"key":"2018_CR3","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1146\/annurev-bioeng-071516-044546","volume":"19","author":"L Yang","year":"2017","unstructured":"Yang L, Venneti S, Nagrath D. Glutaminolysis: a hallmark of cancer metabolism. Annu Rev Biomed Eng. 2017;19:163\u201394. https:\/\/doi.org\/10.1146\/annurev-bioeng-071516-044546.","journal-title":"Annu Rev Biomed Eng"},{"key":"2018_CR4","unstructured":"\u201cOn the Origin of Cancer Cells | Science.\u201d Accessed: Aug. 24, 2023. [Online]. Available: https:\/\/www.science.org\/doi\/10.1126\/science.123.3191.309?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed."},{"issue":"3","key":"2018_CR5","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.ccr.2012.02.014","volume":"21","author":"PS Ward","year":"2012","unstructured":"Ward PS, Thompson CB. Metabolic reprogramming: a cancer hallmark even warburg did not anticipate. Cancer Cell. 2012;21(3):297\u2013308. https:\/\/doi.org\/10.1016\/j.ccr.2012.02.014.","journal-title":"Cancer Cell"},{"key":"2018_CR6","doi-asserted-by":"publisher","first-page":"115464","DOI":"10.1016\/j.bcp.2023.115464","volume":"210","author":"S Li","year":"2023","unstructured":"Li S, et al. Glutamine metabolism in breast cancer and possible therapeutic targets. Biochem Pharmacol. 2023;210:115464. https:\/\/doi.org\/10.1016\/j.bcp.2023.115464.","journal-title":"Biochem Pharmacol"},{"issue":"2","key":"2018_CR7","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/onc.2016.198","volume":"36","author":"BI Ratnikov","year":"2017","unstructured":"Ratnikov BI, Scott DA, Osterman AL, Smith JW, Ronai ZA. Metabolic rewiring in melanoma. Oncogene. 2017;36(2):147\u201357. https:\/\/doi.org\/10.1038\/onc.2016.198.","journal-title":"Oncogene"},{"issue":"2","key":"2018_CR8","doi-asserted-by":"publisher","first-page":"192","DOI":"10.4103\/aja2022105","volume":"25","author":"B Zhao","year":"2023","unstructured":"Zhao B, et al. The role of glutamine metabolism in castration-resistant prostate cancer. Asian J Androl. 2023;25(2):192\u20137. https:\/\/doi.org\/10.4103\/aja2022105.","journal-title":"Asian J Androl"},{"issue":"8","key":"2018_CR9","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1016\/j.trecan.2021.04.003","volume":"7","author":"W-H Yang","year":"2021","unstructured":"Yang W-H, Qiu Y, Stamatatos O, Janowitz T, Lukey MJ. Enhancing the efficacy of glutamine metabolism inhibitors in cancer therapy. Trends Cancer. 2021;7(8):790\u2013804. https:\/\/doi.org\/10.1016\/j.trecan.2021.04.003.","journal-title":"Trends Cancer"},{"key":"2018_CR10","doi-asserted-by":"publisher","first-page":"986847","DOI":"10.3389\/fimmu.2022.986847","volume":"13","author":"X Feng","year":"2022","unstructured":"Feng X, Li X, Liu N, Hou N, Sun X, Liu Y. Glutaminolysis and CD4+ T-cell metabolism in autoimmunity: From pathogenesis to therapy prospects. Front Immunol. 2022;13:986847. https:\/\/doi.org\/10.3389\/fimmu.2022.986847.","journal-title":"Front Immunol"},{"issue":"6","key":"2018_CR11","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.3390\/nu12061675","volume":"12","author":"PM Anderson","year":"2020","unstructured":"Anderson PM, Lalla RV. Glutamine for amelioration of radiation and chemotherapy associated mucositis during cancer therapy. Nutrients. 2020;12(6):1675. https:\/\/doi.org\/10.3390\/nu12061675.","journal-title":"Nutrients"},{"issue":"10","key":"2018_CR12","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.15252\/embj.201696151","volume":"36","author":"J Zhang","year":"2017","unstructured":"Zhang J, Pavlova NN, Thompson CB. Cancer cell metabolism: the essential role of the nonessential amino acid, glutamine. EMBO J. 2017;36(10):1302\u201315. https:\/\/doi.org\/10.15252\/embj.201696151.","journal-title":"EMBO J"},{"issue":"3","key":"2018_CR13","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.trecan.2017.01.005","volume":"3","author":"AA Cluntun","year":"2017","unstructured":"Cluntun AA, Lukey MJ, Cerione RA, Locasale JW. Glutamine metabolism in cancer: understanding the heterogeneity. Trends Cancer. 2017;3(3):169\u201380. https:\/\/doi.org\/10.1016\/j.trecan.2017.01.005.","journal-title":"Trends Cancer"},{"issue":"7","key":"2018_CR14","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1182\/blood-2018-03-834440","volume":"132","author":"CT Quinn","year":"2018","unstructured":"Quinn CT. l-Glutamine for sickle cell anemia: more questions than answers. Blood. 2018;132(7):689\u201393. https:\/\/doi.org\/10.1182\/blood-2018-03-834440.","journal-title":"Blood"},{"key":"2018_CR15","doi-asserted-by":"publisher","unstructured":"E. H, \u201cNutrition needs of mammalian cells in tissue culture.\u201d Science (New York, N.Y.).1955;122(3168). https:\/\/doi.org\/10.1126\/science.122.3168.501.","DOI":"10.1126\/science.122.3168.501"},{"issue":"11","key":"2018_CR16","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.3390\/nu10111564","volume":"10","author":"V Cruzat","year":"2018","unstructured":"Cruzat V, Macedo Rogero M, Noel Keane K, Curi R, Newsholme P. Glutamine: metabolism and immune function, supplementation and clinical translation. Nutrients. 2018;10(11):1564. https:\/\/doi.org\/10.3390\/nu10111564.","journal-title":"Nutrients"},{"key":"2018_CR17","unstructured":"\u201cTargeting cancer metabolism: a therapeutic window opens | Nature Reviews Drug Discovery.\u201d Accessed: Dec. 06, 2024. [Online]. Available: https:\/\/www.nature.com\/articles\/nrd3504."},{"issue":"12","key":"2018_CR18","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1007\/s002680010269","volume":"24","author":"BI Labow","year":"2000","unstructured":"Labow BI, Souba WW. Glutamine. World J Surg. 2000;24(12):1503\u201313. https:\/\/doi.org\/10.1007\/s002680010269.","journal-title":"World J Surg"},{"issue":"2","key":"2018_CR19","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.cmet.2019.11.020","volume":"31","author":"HC Yoo","year":"2020","unstructured":"Yoo HC, et al. A variant of SLC1A5 is a mitochondrial glutamine transporter for metabolic reprogramming in cancer cells. Cell Metab. 2020;31(2):267-283.e12. https:\/\/doi.org\/10.1016\/j.cmet.2019.11.020.","journal-title":"Cell Metab"},{"issue":"24","key":"2018_CR20","doi-asserted-by":"publisher","first-page":"4729","DOI":"10.1038\/s41388-019-0751-4","volume":"38","author":"M Kim","year":"2019","unstructured":"Kim M, Gwak J, Hwang S, Yang S, Jeong SM. Mitochondrial GPT2 plays a pivotal role in metabolic adaptation to the perturbation of mitochondrial glutamine metabolism. Oncogene. 2019;38(24):4729\u201338. https:\/\/doi.org\/10.1038\/s41388-019-0751-4.","journal-title":"Oncogene"},{"issue":"1","key":"2018_CR21","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.molmed.2019.11.004","volume":"26","author":"ZE Stine","year":"2020","unstructured":"Stine ZE, Dang CV. Glutamine Skipping the Q into Mitochondria. Trends Mol Med. 2020;26(1):6\u20137. https:\/\/doi.org\/10.1016\/j.molmed.2019.11.004.","journal-title":"Trends Mol Med"},{"issue":"49","key":"2018_CR22","doi-asserted-by":"publisher","first-page":"19611","DOI":"10.1073\/pnas.1117773108","volume":"108","author":"DR Wise","year":"2011","unstructured":"Wise DR, et al. Hypoxia promotes isocitrate dehydrogenase-dependent carboxylation of \u03b1-ketoglutarate to citrate to support cell growth and viability. Proc Natl Acad Sci U S A. 2011;108(49):19611\u20136. https:\/\/doi.org\/10.1073\/pnas.1117773108.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"2018_CR23","doi-asserted-by":"publisher","first-page":"188724","DOI":"10.1016\/j.bbcan.2022.188724","volume":"1877","author":"N Liu","year":"2022","unstructured":"Liu N, Shi F, Yang L, Liao W, Cao Y. Oncogenic viral infection and amino acid metabolism in cancer progression: Molecular insights and clinical implications. Biochim Biophys Acta Rev Cancer. 2022;1877(3):188724. https:\/\/doi.org\/10.1016\/j.bbcan.2022.188724.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"issue":"1","key":"2018_CR24","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1017\/S0029665122002749","volume":"82","author":"P Newsholme","year":"2023","unstructured":"Newsholme P, Diniz VLS, Dodd GT, Cruzat V. Glutamine metabolism and optimal immune and CNS function. Proc Nutr Soc. 2023;82(1):22\u201331. https:\/\/doi.org\/10.1017\/S0029665122002749.","journal-title":"Proc Nutr Soc"},{"key":"2018_CR25","doi-asserted-by":"publisher","first-page":"e36158","DOI":"10.7554\/eLife.36158","volume":"7","author":"G Lian","year":"2018","unstructured":"Lian G, et al. Glutathione de novo synthesis but not recycling process coordinates with glutamine catabolism to control redox homeostasis and directs murine T cell differentiation. Elife. 2018;7:e36158. https:\/\/doi.org\/10.7554\/eLife.36158.","journal-title":"Elife"},{"issue":"12","key":"2018_CR26","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1038\/s42255-023-00919-3","volume":"5","author":"SJ Linder","year":"2023","unstructured":"Linder SJ, et al. Inhibition of the proline metabolism rate-limiting enzyme P5CS allows proliferation of glutamine-restricted cancer cells. Nat Metab. 2023;5(12):2131\u201347. https:\/\/doi.org\/10.1038\/s42255-023-00919-3.","journal-title":"Nat Metab"},{"issue":"1","key":"2018_CR27","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrclinonc.2016.60","volume":"14","author":"UE Martinez-Outschoorn","year":"2017","unstructured":"Martinez-Outschoorn UE, Peiris-Pag\u00e9s M, Pestell RG, Sotgia F, Lisanti MP. Cancer metabolism: a therapeutic perspective. Nat Rev Clin Oncol. 2017;14(1):11\u201331. https:\/\/doi.org\/10.1038\/nrclinonc.2016.60.","journal-title":"Nat Rev Clin Oncol"},{"key":"2018_CR28","doi-asserted-by":"publisher","first-page":"154778","DOI":"10.1016\/j.metabol.2021.154778","volume":"121","author":"Y Shen","year":"2021","unstructured":"Shen Y, Zhang Y, Li W, Chen K, Xiang M, Ma H. Glutamine metabolism: from proliferating cells to cardiomyocytes. Metabolism. 2021;121:154778. https:\/\/doi.org\/10.1016\/j.metabol.2021.154778.","journal-title":"Metabolism"},{"issue":"3","key":"2018_CR29","doi-asserted-by":"publisher","first-page":"2337","DOI":"10.3390\/ijms24032337","volume":"24","author":"F Pacifico","year":"2023","unstructured":"Pacifico F, Leonardi A, Crescenzi E. Glutamine metabolism in cancer stem cells: a complex liaison in the tumor microenvironment. Int J Mol Sci. 2023;24(3):2337. https:\/\/doi.org\/10.3390\/ijms24032337.","journal-title":"Int J Mol Sci"},{"key":"2018_CR30","doi-asserted-by":"publisher","first-page":"174723","DOI":"10.1016\/j.ejphar.2021.174723","volume":"916","author":"HM Fares","year":"2022","unstructured":"Fares HM, et al. Autophagy in cancer: the cornerstone during glutamine deprivation. Eur J Pharmacol. 2022;916:174723. https:\/\/doi.org\/10.1016\/j.ejphar.2021.174723.","journal-title":"Eur J Pharmacol"},{"issue":"8","key":"2018_CR31","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1007\/s11864-023-01104-0","volume":"24","author":"Y Xiao","year":"2023","unstructured":"Xiao Y, et al. Targeting glutamine metabolism as an attractive therapeutic strategy for acute myeloid leukemia. Curr Treat Options Oncol. 2023;24(8):1021\u201335. https:\/\/doi.org\/10.1007\/s11864-023-01104-0.","journal-title":"Curr Treat Options Oncol"},{"key":"2018_CR32","doi-asserted-by":"publisher","first-page":"114943","DOI":"10.1016\/j.bcp.2022.114943","volume":"198","author":"S Sharma","year":"2022","unstructured":"Sharma S, Agnihotri N, Kumar S. Targeting fuel pocket of cancer cell metabolism: a focus on glutaminolysis. Biochem Pharmacol. 2022;198:114943. https:\/\/doi.org\/10.1016\/j.bcp.2022.114943.","journal-title":"Biochem Pharmacol"},{"issue":"13","key":"2018_CR33","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1182\/blood.2019001034","volume":"134","author":"Y Tabe","year":"2019","unstructured":"Tabe Y, Lorenzi PL, Konopleva M. Amino acid metabolism in hematologic malignancies and the era of targeted therapy. Blood. 2019;134(13):1014\u201323. https:\/\/doi.org\/10.1182\/blood.2019001034.","journal-title":"Blood"},{"issue":"4","key":"2018_CR34","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1038\/s12276-023-00971-9","volume":"55","author":"J Jin","year":"2023","unstructured":"Jin J, Byun J-K, Choi Y-K, Park K-G. Targeting glutamine metabolism as a therapeutic strategy for cancer. Exp Mol Med. 2023;55(4):706\u201315. https:\/\/doi.org\/10.1038\/s12276-023-00971-9.","journal-title":"Exp Mol Med"},{"key":"2018_CR35","doi-asserted-by":"publisher","unstructured":"Z. L, Z. X, and W. Y, \u201cEffects of Glucose Metabolism, Lipid Metabolism, and Glutamine Metabolism on Tumor Microenvironment and Clinical Implications.\u201d Biomolecules. 2022; 12(4).https:\/\/doi.org\/10.3390\/biom12040580.","DOI":"10.3390\/biom12040580"},{"issue":"34","key":"2018_CR36","doi-asserted-by":"publisher","first-page":"4066","DOI":"10.1038\/s41388-022-02408-5","volume":"41","author":"L-E Quek","year":"2022","unstructured":"Quek L-E, et al. Glutamine addiction promotes glucose oxidation in triple-negative breast cancer. Oncogene. 2022;41(34):4066\u201378. https:\/\/doi.org\/10.1038\/s41388-022-02408-5.","journal-title":"Oncogene"},{"issue":"Pt 3","key":"2018_CR37","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.semcancer.2022.03.023","volume":"86","author":"C Zhang","year":"2022","unstructured":"Zhang C, Quinones A, Le A. Metabolic reservoir cycles in cancer. Semin Cancer Biol. 2022;86(Pt 3):180\u20138. https:\/\/doi.org\/10.1016\/j.semcancer.2022.03.023.","journal-title":"Semin Cancer Biol"},{"issue":"1","key":"2018_CR38","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s13045-020-01030-w","volume":"14","author":"J Tao","year":"2021","unstructured":"Tao J, et al. Targeting hypoxic tumor microenvironment in pancreatic cancer. J Hematol Oncol. 2021;14(1):14. https:\/\/doi.org\/10.1186\/s13045-020-01030-w.","journal-title":"J Hematol Oncol"},{"issue":"12","key":"2018_CR39","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1038\/s42255-020-00315-1","volume":"2","author":"S Raho","year":"2020","unstructured":"Raho S, et al. KRAS-regulated glutamine metabolism requires UCP2-mediated aspartate transport to support pancreatic cancer growth. Nat Metab. 2020;2(12):1373\u201381. https:\/\/doi.org\/10.1038\/s42255-020-00315-1.","journal-title":"Nat Metab"},{"issue":"2","key":"2018_CR40","doi-asserted-by":"publisher","first-page":"166982","DOI":"10.1016\/j.bbadis.2023.166982","volume":"1870","author":"W Xue","year":"2024","unstructured":"Xue W, et al. The pan-cancer landscape of glutamate and glutamine metabolism: a comprehensive bioinformatic analysis across 32 solid cancer types. Biochim Biophys Acta Mol Basis Dis. 2024;1870(2):166982. https:\/\/doi.org\/10.1016\/j.bbadis.2023.166982.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"2","key":"2018_CR41","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.celrep.2019.03.036","volume":"27","author":"T Nguyen","year":"2019","unstructured":"Nguyen T, et al. Uncovering the Role of N-Acetyl-Aspartyl-Glutamate as a Glutamate Reservoir in Cancer. Cell Rep. 2019;27(2):491-501.e6. https:\/\/doi.org\/10.1016\/j.celrep.2019.03.036.","journal-title":"Cell Rep"},{"issue":"1","key":"2018_CR42","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s12964-023-01449-x","volume":"22","author":"X Li","year":"2024","unstructured":"Li X, et al. Glutamine addiction in tumor cell: oncogene regulation and clinical treatment. Cell Commun Signal. 2024;22(1):12. https:\/\/doi.org\/10.1186\/s12964-023-01449-x.","journal-title":"Cell Commun Signal"},{"issue":"1","key":"2018_CR43","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3390\/ijms24010012","volume":"24","author":"H-S Chae","year":"2022","unstructured":"Chae H-S, Hong S-T. Overview of cancer metabolism and signaling transduction. Int J Mol Sci. 2022;24(1):12. https:\/\/doi.org\/10.3390\/ijms24010012.","journal-title":"Int J Mol Sci"},{"key":"2018_CR44","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.cmet.2011.12.015","volume":"15","author":"MO Yuneva","year":"2012","unstructured":"Yuneva MO, Fan TW, Allen TD, Higashi RM, Ferraris DV, Tsukamoto T, Mates JM, Alonso FJ, Wang C, Seo Y, Chen X, Bishop JM. The metabolic profile of tumors depends on both the responsible genetic lesion and tissue type. Cell Metab. 2012;15:157\u201370.","journal-title":"Cell Metab"},{"issue":"23","key":"2018_CR45","doi-asserted-by":"publisher","first-page":"3409","DOI":"10.15252\/embj.201796438","volume":"36","author":"FR Dejure","year":"2017","unstructured":"Dejure FR, Eilers M. MYC and tumor metabolism: chicken and egg. EMBO J. 2017;36(23):3409\u201320. https:\/\/doi.org\/10.15252\/embj.201796438.","journal-title":"EMBO J"},{"issue":"3","key":"2018_CR46","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/s41568-020-00320-2","volume":"21","author":"G Bergers","year":"2021","unstructured":"Bergers G, Fendt S-M. The metabolism of cancer cells during metastasis. Nat Rev Cancer. 2021;21(3):162\u201380. https:\/\/doi.org\/10.1038\/s41568-020-00320-2.","journal-title":"Nat Rev Cancer"},{"issue":"6468","key":"2018_CR47","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1126\/science.aav2588","volume":"366","author":"RD Leone","year":"2019","unstructured":"Leone RD, et al. Glutamine blockade induces divergent metabolic programs to overcome tumor immune evasion. Science. 2019;366(6468):1013\u201321. https:\/\/doi.org\/10.1126\/science.aav2588.","journal-title":"Science"},{"issue":"42","key":"2018_CR48","doi-asserted-by":"publisher","first-page":"3127","DOI":"10.1038\/s41388-023-02795-3","volume":"42","author":"D Du","year":"2023","unstructured":"Du D, et al. RNA binding motif protein 45-mediated phosphorylation enhances protein stability of ASCT2 to promote hepatocellular carcinoma progression. Oncogene. 2023;42(42):3127\u201341. https:\/\/doi.org\/10.1038\/s41388-023-02795-3.","journal-title":"Oncogene"},{"issue":"13","key":"2018_CR49","doi-asserted-by":"publisher","first-page":"6038","DOI":"10.7150\/thno.73896","volume":"12","author":"S Cao","year":"2022","unstructured":"Cao S, et al. Glutamine is essential for overcoming the immunosuppressive microenvironment in malignant salivary gland tumors. Theranostics. 2022;12(13):6038\u201356. https:\/\/doi.org\/10.7150\/thno.73896.","journal-title":"Theranostics"},{"key":"2018_CR50","doi-asserted-by":"publisher","first-page":"107292","DOI":"10.1016\/j.phrs.2024.107292","volume":"206","author":"X Wang","year":"2024","unstructured":"Wang X, Gong W, Xiong X, Jia X, Xu J. Asparagine: a key metabolic junction in targeted tumor therapy. Pharmacol Res. 2024;206:107292. https:\/\/doi.org\/10.1016\/j.phrs.2024.107292.","journal-title":"Pharmacol Res"},{"issue":"11","key":"2018_CR51","doi-asserted-by":"publisher","first-page":"e392","DOI":"10.1097\/RLU.0000000000002257","volume":"43","author":"X Xu","year":"2018","unstructured":"Xu X, et al. Imaging Brain Metastasis Patients With 18F-(2S,4R)-4-Fluoroglutamine. Clin Nucl Med. 2018;43(11):e392\u20139. https:\/\/doi.org\/10.1097\/RLU.0000000000002257.","journal-title":"Clin Nucl Med"},{"issue":"4","key":"2018_CR52","doi-asserted-by":"publisher","first-page":"533","DOI":"10.2967\/jnumed.116.182345","volume":"58","author":"L Zhu","year":"2017","unstructured":"Zhu L, Ploessl K, Zhou R, Mankoff D, Kung HF. Metabolic Imaging of Glutamine in Cancer. J Nucl Med. 2017;58(4):533\u20137. https:\/\/doi.org\/10.2967\/jnumed.116.182345.","journal-title":"J Nucl Med"},{"issue":"1","key":"2018_CR53","doi-asserted-by":"publisher","first-page":"5511","DOI":"10.1038\/s41598-022-09529-7","volume":"12","author":"Y Seo","year":"2022","unstructured":"Seo Y, Kang J, Kim TI, Joo CG. MRI assessment of glutamine uptake correlates with the distribution of glutamine transporters and cancer stem cell markers. Sci Rep. 2022;12(1):5511. https:\/\/doi.org\/10.1038\/s41598-022-09529-7.","journal-title":"Sci Rep"},{"issue":"4","key":"2018_CR54","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/j.suc.2011.04.004","volume":"91","author":"S Jayarajan","year":"2011","unstructured":"Jayarajan S, Daly JM. The relationships of nutrients, routes of delivery, and immunocompetence. Surg Clin North Am. 2011;91(4):737\u201353. https:\/\/doi.org\/10.1016\/j.suc.2011.04.004. vii.","journal-title":"Surg Clin North Am"},{"issue":"5","key":"2018_CR55","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.smim.2016.09.003","volume":"28","author":"MO Johnson","year":"2016","unstructured":"Johnson MO, Siska PJ, Contreras DC, Rathmell JC. Nutrients and the microenvironment to feed a T cell army. Semin Immunol. 2016;28(5):505\u201313. https:\/\/doi.org\/10.1016\/j.smim.2016.09.003.","journal-title":"Semin Immunol"},{"issue":"7","key":"2018_CR56","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1038\/s42255-019-0084-1","volume":"1","author":"I Clerc","year":"2019","unstructured":"Clerc I, et al. Entry of glucose- and glutamine-derived carbons into the citric acid cycle supports early steps of HIV-1 infection in CD4 T cells. Nat Metab. 2019;1(7):717\u201330. https:\/\/doi.org\/10.1038\/s42255-019-0084-1.","journal-title":"Nat Metab"},{"issue":"1","key":"2018_CR57","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/s12964-022-00909-0","volume":"20","author":"G Ma","year":"2022","unstructured":"Ma G, et al. Reprogramming of glutamine metabolism and its impact on immune response in the tumor microenvironment. Cell Commun Signal. 2022;20(1):114. https:\/\/doi.org\/10.1186\/s12964-022-00909-0.","journal-title":"Cell Commun Signal"},{"key":"2018_CR58","doi-asserted-by":"publisher","first-page":"962175","DOI":"10.3389\/fimmu.2022.962175","volume":"13","author":"D Mart\u00ednez-M\u00e9ndez","year":"2022","unstructured":"Mart\u00ednez-M\u00e9ndez D, Huerta L, Villarreal C. Modeling the effect of environmental cytokines, nutrient conditions and hypoxia on CD4+ T cell differentiation. Front Immunol. 2022;13:962175. https:\/\/doi.org\/10.3389\/fimmu.2022.962175.","journal-title":"Front Immunol"},{"key":"2018_CR59","doi-asserted-by":"publisher","first-page":"101569","DOI":"10.1016\/j.tice.2021.101569","volume":"71","author":"G Li","year":"2021","unstructured":"Li G, Liu L, Yin Z, Ye Z, Shen N. Glutamine metabolism is essential for the production of IL-17A in \u03b3\u03b4 T cells and skin inflammation. Tissue Cell. 2021;71:101569. https:\/\/doi.org\/10.1016\/j.tice.2021.101569.","journal-title":"Tissue Cell"},{"issue":"3","key":"2018_CR60","doi-asserted-by":"publisher","first-page":"e2655","DOI":"10.1038\/cddis.2016.222","volume":"8","author":"W Ren","year":"2017","unstructured":"Ren W, et al. Amino-acid transporters in T-cell activation and differentiation. Cell Death Dis. 2017;8(3):e2655. https:\/\/doi.org\/10.1038\/cddis.2016.222.","journal-title":"Cell Death Dis"},{"key":"2018_CR61","doi-asserted-by":"publisher","unstructured":"E. A. R, M. A, C. Ml, E. Io, R. Ea, and G. Ar. \u201cAltered glutamine metabolism in breast cancer; subtype dependencies and alternative adaptations.\u201d Histopathology. 2018;72(2). https:\/\/doi.org\/10.1111\/his.13334.","DOI":"10.1111\/his.13334"},{"issue":"12","key":"2018_CR62","doi-asserted-by":"publisher","first-page":"3737","DOI":"10.1111\/cas.13827","volume":"109","author":"S Nabe","year":"2018","unstructured":"Nabe S, et al. Reinforce the antitumor activity of CD8+ T cells via glutamine restriction. Cancer Sci. 2018;109(12):3737\u201350. https:\/\/doi.org\/10.1111\/cas.13827.","journal-title":"Cancer Sci"},{"issue":"1","key":"2018_CR63","doi-asserted-by":"publisher","first-page":"3296","DOI":"10.1038\/s41467-018-05854-6","volume":"9","author":"J Suzuki","year":"2018","unstructured":"Suzuki J, et al. The tumor suppressor menin prevents effector CD8 T-cell dysfunction by targeting mTORC1-dependent metabolic activation. Nat Commun. 2018;9(1):3296. https:\/\/doi.org\/10.1038\/s41467-018-05854-6.","journal-title":"Nat Commun"},{"issue":"7","key":"2018_CR64","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.4049\/jimmunol.1901480","volume":"205","author":"R Vallion","year":"2020","unstructured":"Vallion R, et al. Regulatory T Cell stability and migration are dependent on mTOR. J Immunol. 2020;205(7):1799\u2013809. https:\/\/doi.org\/10.4049\/jimmunol.1901480.","journal-title":"J Immunol"},{"key":"2018_CR65","doi-asserted-by":"publisher","unstructured":"E. Dn et al., \u201cSelective glutamine metabolism inhibition in tumor cells improves antitumor T lymphocyte activity in triple-negative breast cancer.\u201d J Clin Invest. 2021; 131(4). https:\/\/doi.org\/10.1172\/JCI140100.","DOI":"10.1172\/JCI140100"},{"issue":"5","key":"2018_CR66","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1002\/ijc.34059","volume":"151","author":"A Madi","year":"2022","unstructured":"Madi A, et al. CD8 agonism functionally activates memory T cells and enhances antitumor immunity. Int J Cancer. 2022;151(5):797\u2013808. https:\/\/doi.org\/10.1002\/ijc.34059.","journal-title":"Int J Cancer"},{"issue":"1","key":"2018_CR67","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.cmet.2017.10.006","volume":"27","author":"S Chatterjee","year":"2018","unstructured":"Chatterjee S, et al. CD38-NAD+Axis Regulates Immunotherapeutic Anti-Tumor T Cell Response. Cell Metab. 2018;27(1):85-100.e8. https:\/\/doi.org\/10.1016\/j.cmet.2017.10.006.","journal-title":"Cell Metab"},{"issue":"12","key":"2018_CR68","doi-asserted-by":"publisher","first-page":"3694","DOI":"10.1111\/febs.15715","volume":"288","author":"M Kieler","year":"2021","unstructured":"Kieler M, Hofmann M, Schabbauer G. More than just protein building blocks: how amino acids and related metabolic pathways fuel macrophage polarization. FEBS J. 2021;288(12):3694\u2013714. https:\/\/doi.org\/10.1111\/febs.15715.","journal-title":"FEBS J"},{"issue":"3","key":"2018_CR69","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1080\/08830185.2020.1712379","volume":"39","author":"Y Liu","year":"2020","unstructured":"Liu Y, et al. BCG-induced trained immunity in macrophage: reprograming of glucose metabolism. Int Rev Immunol. 2020;39(3):83\u201396. https:\/\/doi.org\/10.1080\/08830185.2020.1712379.","journal-title":"Int Rev Immunol"},{"issue":"7","key":"2018_CR70","doi-asserted-by":"publisher","first-page":"8753","DOI":"10.1021\/acsami.1c21417","volume":"14","author":"B Du","year":"2022","unstructured":"Du B, et al. Glutamine metabolism-regulated nanoparticles to enhance chemoimmunotherapy by increasing antigen presentation efficiency. ACS Appl Mater Interfaces. 2022;14(7):8753\u201365. https:\/\/doi.org\/10.1021\/acsami.1c21417.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"5","key":"2018_CR71","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1016\/j.eururo.2018.09.030","volume":"75","author":"Q Fu","year":"2019","unstructured":"Fu Q, et al. Tumor-associated macrophage-derived interleukin-23 interlinks kidney cancer glutamine addiction with immune evasion. Eur Urol. 2019;75(5):752\u201363. https:\/\/doi.org\/10.1016\/j.eururo.2018.09.030.","journal-title":"Eur Urol"},{"issue":"9","key":"2018_CR72","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1038\/ni.3796","volume":"18","author":"P-S Liu","year":"2017","unstructured":"Liu P-S, et al. \u03b1-ketoglutarate orchestrates macrophage activation through metabolic and epigenetic reprogramming. Nat Immunol. 2017;18(9):985\u201394. https:\/\/doi.org\/10.1038\/ni.3796.","journal-title":"Nat Immunol"},{"key":"2018_CR73","doi-asserted-by":"publisher","first-page":"960738","DOI":"10.3389\/fimmu.2022.960738","volume":"13","author":"J Liu","year":"2022","unstructured":"Liu J, et al. Prediction of prognosis, immunogenicity and efficacy of immunotherapy based on glutamine metabolism in lung adenocarcinoma. Front Immunol. 2022;13:960738. https:\/\/doi.org\/10.3389\/fimmu.2022.960738.","journal-title":"Front Immunol"},{"issue":"15\u201316","key":"2018_CR74","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1101\/gad.312355.118","volume":"32","author":"VL Nelson","year":"2018","unstructured":"Nelson VL, et al. PPAR\u03b3 is a nexus controlling alternative activation of macrophages via glutamine metabolism. Genes Dev. 2018;32(15\u201316):1035\u201344. https:\/\/doi.org\/10.1101\/gad.312355.118.","journal-title":"Genes Dev"},{"issue":"7","key":"2018_CR75","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1016\/j.celrep.2017.07.054","volume":"20","author":"EM Palmieri","year":"2017","unstructured":"Palmieri EM, et al. Pharmacologic or Genetic Targeting of Glutamine Synthetase Skews Macrophages toward an M1-like Phenotype and Inhibits Tumor Metastasis. Cell Rep. 2017;20(7):1654\u201366. https:\/\/doi.org\/10.1016\/j.celrep.2017.07.054.","journal-title":"Cell Rep"},{"issue":"1","key":"2018_CR76","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3390\/medsci6010022","volume":"6","author":"RS Hesterberg","year":"2018","unstructured":"Hesterberg RS, Cleveland JL, Epling-Burnette PK. Role of Polyamines in Immune Cell Functions. Med Sci (Basel). 2018;6(1):22. https:\/\/doi.org\/10.3390\/medsci6010022.","journal-title":"Med Sci (Basel)"},{"issue":"5","key":"2018_CR77","doi-asserted-by":"publisher","first-page":"231","DOI":"10.4049\/immunohorizons.2000020","volume":"4","author":"SR Presnell","year":"2020","unstructured":"Presnell SR, Spear HK, Durham J, Riddle T, Applegate A, Lutz CT. Differential Fuel Requirements of Human NK Cells and Human CD8 T Cells: Glutamine Regulates Glucose Uptake in Strongly Activated CD8 T Cells. Immunohorizons. 2020;4(5):231\u201344. https:\/\/doi.org\/10.4049\/immunohorizons.2000020.","journal-title":"Immunohorizons"},{"issue":"6","key":"2018_CR78","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1002\/mnfr.201500884","volume":"60","author":"NB Janakiram","year":"2016","unstructured":"Janakiram NB, Mohammed A, Madka V, Kumar G, Rao CV. Prevention and treatment of cancers by immune modulating nutrients. Mol Nutr Food Res. 2016;60(6):1275\u201394. https:\/\/doi.org\/10.1002\/mnfr.201500884.","journal-title":"Mol Nutr Food Res"},{"issue":"9","key":"2018_CR79","doi-asserted-by":"publisher","first-page":"2547","DOI":"10.18632\/aging.101968","volume":"11","author":"S Jiang","year":"2019","unstructured":"Jiang S, Yan W, Wang SE. MicroRNA Let-7 in B lymphocyte activation. Aging (Albany NY). 2019;11(9):2547\u20138. https:\/\/doi.org\/10.18632\/aging.101968.","journal-title":"Aging (Albany NY)"},{"key":"2018_CR80","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-023-06299-8","author":"C Guo","year":"2023","unstructured":"Guo C, et al. SLC38A2 and glutamine signalling in cDC1s dictate anti-tumour immunity. Nature. 2023. https:\/\/doi.org\/10.1038\/s41586-023-06299-8.","journal-title":"Nature"},{"issue":"5","key":"2018_CR81","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.cmet.2016.10.011","volume":"24","author":"L Yang","year":"2016","unstructured":"Yang L, et al. Targeting stromal glutamine synthetase in tumors disrupts tumor microenvironment-regulated cancer cell growth. Cell Metab. 2016;24(5):685\u2013700. https:\/\/doi.org\/10.1016\/j.cmet.2016.10.011.","journal-title":"Cell Metab"},{"issue":"2","key":"2018_CR82","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1158\/0008-5472.CAN-20-0622","volume":"81","author":"A Mestre-Farrera","year":"2021","unstructured":"Mestre-Farrera A, et al. Glutamine-directed migration of cancer-activated fibroblasts facilitates epithelial tumor invasion. Cancer Res. 2021;81(2):438\u201351. https:\/\/doi.org\/10.1158\/0008-5472.CAN-20-0622.","journal-title":"Cancer Res"},{"issue":"1","key":"2018_CR83","doi-asserted-by":"publisher","first-page":"2","DOI":"10.31083\/j.fbe1501002","volume":"15","author":"N Bhowmick","year":"2023","unstructured":"Bhowmick N, et al. Targeting glutamine metabolism in prostate cancer. Front Biosci (Elite Ed). 2023;15(1):2. https:\/\/doi.org\/10.31083\/j.fbe1501002.","journal-title":"Front Biosci (Elite Ed)"},{"issue":"7","key":"2018_CR84","doi-asserted-by":"publisher","first-page":"3865","DOI":"10.1172\/JCI131859","volume":"130","author":"M-H Oh","year":"2020","unstructured":"Oh M-H, et al. Targeting glutamine metabolism enhances tumor-specific immunity by modulating suppressive myeloid cells. J Clin Invest. 2020;130(7):3865\u201384. https:\/\/doi.org\/10.1172\/JCI131859.","journal-title":"J Clin Invest"},{"issue":"12","key":"2018_CR85","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.1248\/bpb.b18-00055","volume":"41","author":"N Morikawa","year":"2018","unstructured":"Morikawa N, Tachibana M, Ago Y, Goda H, Sakurai F, Mizuguchi H. LY341495, an mGluR2\/3 antagonist, regulates the immunosuppressive function of myeloid-derived suppressor cells and inhibits melanoma tumor growth. Biol Pharm Bull. 2018;41(12):1866\u20139. https:\/\/doi.org\/10.1248\/bpb.b18-00055.","journal-title":"Biol Pharm Bull"},{"issue":"3","key":"2018_CR86","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1053\/j.seminhematol.2015.03.002","volume":"52","author":"AT Fathi","year":"2015","unstructured":"Fathi AT, Wander SA, Faramand R, Emadi A. Biochemical, epigenetic, and metabolic approaches to target IDH mutations in acute myeloid leukemia. Semin Hematol. 2015;52(3):165\u201371. https:\/\/doi.org\/10.1053\/j.seminhematol.2015.03.002.","journal-title":"Semin Hematol"},{"issue":"8","key":"2018_CR87","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1016\/j.trecan.2021.04.003","volume":"7","author":"W-H Yang","year":"2021","unstructured":"Yang W-H, Qiu Y, Stamatatos O, Janowitz T, Lukey MJ. Enhancing the efficacy of glutamine metabolism inhibitors in cancer therapy. Trends Cancer. 2021;7(8):790\u2013804. https:\/\/doi.org\/10.1016\/j.trecan.2021.04.003.","journal-title":"Trends Cancer"},{"key":"2018_CR88","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1159\/000061818","volume":"4","author":"G Nitenberg","year":"2000","unstructured":"Nitenberg G, Dechelotte P. Is immune nutrition the Holy Grail for cancer patients? Nestle Nutr Workshop Ser Clin Perform Programme. 2000;4:255\u201372. https:\/\/doi.org\/10.1159\/000061818. discussion 273.","journal-title":"Nestle Nutr Workshop Ser Clin Perform Programme"},{"issue":"1","key":"2018_CR89","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/s43018-023-00647-3","volume":"5","author":"J Encarnaci\u00f3n-Rosado","year":"2024","unstructured":"Encarnaci\u00f3n-Rosado J, et al. Targeting pancreatic cancer metabolic dependencies through glutamine antagonism. Nat Cancer. 2024;5(1):85\u201399. https:\/\/doi.org\/10.1038\/s43018-023-00647-3.","journal-title":"Nat Cancer"},{"key":"2018_CR90","doi-asserted-by":"publisher","unstructured":"N. M. Tannir et al., \u201cCANTATA: Randomized, international, double-blind study of CB-839 plus cabozantinib versus cabozantinib plus placebo in patients with metastatic renal cell carcinoma.\u201d J Clin Oncol. 2019. https:\/\/doi.org\/10.1200\/JCO.2019.37.7_suppl.TPS682.","DOI":"10.1200\/JCO.2019.37.7_suppl.TPS682"},{"key":"2018_CR91","doi-asserted-by":"publisher","first-page":"v889","DOI":"10.1093\/annonc\/mdz394.048","volume":"30","author":"RJ Motzer","year":"2019","unstructured":"Motzer RJ, et al. LBA54 - ENTRATA: Randomized, double-blind, phase II study of telaglenastat (tela; CB-839) + everolimus (E) vs placebo (pbo) + E in patients (pts) with advanced\/metastatic renal cell carcinoma (mRCC). Ann Oncol. 2019;30:v889\u201390. https:\/\/doi.org\/10.1093\/annonc\/mdz394.048.","journal-title":"Ann Oncol"},{"key":"2018_CR92","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1182\/blood-2019-125970","volume":"134","author":"VA Guerra","year":"2019","unstructured":"Guerra VA, et al. Interim Analysis of a Phase II Study of the Glutaminase Inhibitor Telaglenastat (CB-839) in Combination with Azacitidine in Advanced Myelodysplastic Syndrome (MDS). Blood. 2019;134:567. https:\/\/doi.org\/10.1182\/blood-2019-125970.","journal-title":"Blood"},{"issue":"1","key":"2018_CR93","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3892\/ol.2021.13137","volume":"23","author":"A Papanikolopoulou","year":"2022","unstructured":"Papanikolopoulou A, et al. Use of oral glutamine in radiation-induced adverse effects in patients with thoracic and upper aerodigestive malignancies: Results of a prospective observational study. Oncol Lett. 2022;23(1):19. https:\/\/doi.org\/10.3892\/ol.2021.13137.","journal-title":"Oncol Lett"},{"issue":"3","key":"2018_CR94","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1093\/ajcn\/nqy329","volume":"109","author":"C-J Huang","year":"2019","unstructured":"Huang C-J, et al. Randomized double-blind, placebo-controlled trial evaluating oral glutamine on radiation-induced oral mucositis and dermatitis in head and neck cancer patients. Am J Clin Nutr. 2019;109(3):606\u201314. https:\/\/doi.org\/10.1093\/ajcn\/nqy329.","journal-title":"Am J Clin Nutr"},{"issue":"4","key":"2018_CR95","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1007\/s10637-021-01074-w","volume":"39","author":"A Alshawa","year":"2021","unstructured":"Alshawa A, et al. Effects of glutamine for prevention of radiation-induced esophagitis: a double-blind placebo-controlled trial. Invest New Drugs. 2021;39(4):1113\u201322. https:\/\/doi.org\/10.1007\/s10637-021-01074-w.","journal-title":"Invest New Drugs."},{"issue":"3","key":"2018_CR96","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1007\/s00520-016-3441-6","volume":"25","author":"S Sands","year":"2017","unstructured":"Sands S, et al. Glutamine for the treatment of vincristine-induced neuropathy in children and adolescents with cancer. Support Care Cancer. 2017;25(3):701\u20138. https:\/\/doi.org\/10.1007\/s00520-016-3441-6.","journal-title":"Support Care Cancer"},{"issue":"9","key":"2018_CR97","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1200\/JCO.2003.05.060","volume":"21","author":"TF Kozelsky","year":"2003","unstructured":"Kozelsky TF, et al. Phase III double-blind study of glutamine versus placebo for the prevention of acute diarrhea in patients receiving pelvic radiation therapy. J Clin Oncol. 2003;21(9):1669\u201374. https:\/\/doi.org\/10.1200\/JCO.2003.05.060.","journal-title":"J Clin Oncol."},{"issue":"2","key":"2018_CR98","doi-asserted-by":"publisher","first-page":"223","DOI":"10.2174\/18715206113136660374","volume":"14","author":"M Villalba","year":"2014","unstructured":"Villalba M, et al. Chemical metabolic inhibitors for the treatment of blood-borne cancers. Anticancer Agents Med Chem. 2014;14(2):223\u201332. https:\/\/doi.org\/10.2174\/18715206113136660374.","journal-title":"Anticancer Agents Med Chem"},{"issue":"13","key":"2018_CR99","doi-asserted-by":"publisher","first-page":"eado7808","DOI":"10.1126\/sciadv.ado7808","volume":"10","author":"EB Blatt","year":"2024","unstructured":"Blatt EB, DeBerardinis RJ. Glutamine antagonists may KEAP lung cancer in check. Sci Adv. 2024;10(13):eado7808.","journal-title":"Sci Adv"},{"issue":"2","key":"2018_CR100","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.cmet.2017.12.006","volume":"27","author":"NN Pavlova","year":"2018","unstructured":"Pavlova NN, et al. As extracellular glutamine levels decline, asparagine becomes an essential amino acid. Cell Metab. 2018;27(2):428-438.e5. https:\/\/doi.org\/10.1016\/j.cmet.2017.12.006.","journal-title":"Cell Metab"},{"issue":"1","key":"2018_CR101","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/s43018-023-00649-1","volume":"5","author":"MV Recouvreux","year":"2024","unstructured":"Recouvreux MV, et al. Glutamine mimicry suppresses tumor progression through asparagine metabolism in pancreatic ductal adenocarcinoma. Nat Cancer. 2024;5(1):100\u201313. https:\/\/doi.org\/10.1038\/s43018-023-00649-1.","journal-title":"Nat Cancer"},{"issue":"9","key":"2018_CR102","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1056\/NEJMcibr1914890","volume":"382","author":"RJ DeBerardinis","year":"2020","unstructured":"DeBerardinis RJ. Tumor Microenvironment, Metabolism, and immunotherapy. n engl j med. 2020;382(9):869\u201371. https:\/\/doi.org\/10.1056\/NEJMcibr1914890.","journal-title":"n engl j med"},{"issue":"26","key":"2018_CR103","doi-asserted-by":"publisher","first-page":"e2105885","DOI":"10.1002\/advs.202105885","volume":"9","author":"M Huang","year":"2022","unstructured":"Huang M, et al. Targeting Glutamine Metabolism to Enhance Immunoprevention of EGFR-Driven Lung Cancer. Adv Sci (Weinh). 2022;9(26):e2105885. https:\/\/doi.org\/10.1002\/advs.202105885.","journal-title":"Adv Sci (Weinh)"},{"key":"2018_CR104","doi-asserted-by":"publisher","unstructured":"Y. W, Y. X, Z. Q, S. L, Y. S, and X. Y, \u201cTargeting GLS1 to cancer therapy through glutamine metabolism,\u201d Clinical & translational oncology\u202f: official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. 2021; 23(11). https:\/\/doi.org\/10.1007\/s12094-021-02645-2.","DOI":"10.1007\/s12094-021-02645-2"},{"key":"2018_CR105","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.bcp.2018.03.006","volume":"151","author":"C Fumarola","year":"2018","unstructured":"Fumarola C, Petronini PG, Alfieri R. Impairing energy metabolism in solid tumors through agents targeting oncogenic signaling pathways. Biochem Pharmacol. 2018;151:114\u201325. https:\/\/doi.org\/10.1016\/j.bcp.2018.03.006.","journal-title":"Biochem Pharmacol"},{"issue":"28","key":"2018_CR106","doi-asserted-by":"publisher","first-page":"3619","DOI":"10.1038\/onc.2015.447","volume":"35","author":"L Jin","year":"2016","unstructured":"Jin L, Alesi GN, Kang S. Glutaminolysis as a target for cancer therapy. Oncogene. 2016;35(28):3619\u201325. https:\/\/doi.org\/10.1038\/onc.2015.447.","journal-title":"Oncogene"},{"issue":"8","key":"2018_CR107","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s13238-020-00789-5","volume":"12","author":"P Koppula","year":"2021","unstructured":"Koppula P, Zhuang L, Gan B. Cystine transporter SLC7A11\/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy. Protein Cell. 2021;12(8):599\u2013620. https:\/\/doi.org\/10.1007\/s13238-020-00789-5.","journal-title":"Protein Cell"},{"key":"2018_CR108","doi-asserted-by":"publisher","unstructured":"V. K et al., \u201cglutamine addiction and therapeutic strategies in lung cancer,\u201d Int J Mol Sci. 2019; 20(2). https:\/\/doi.org\/10.3390\/ijms20020252.","DOI":"10.3390\/ijms20020252"},{"issue":"2","key":"2018_CR109","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1038\/s43018-020-00160-x","volume":"2","author":"S Wu","year":"2021","unstructured":"Wu S, et al. Targeting glutamine dependence through GLS1 inhibition suppresses ARID1A-inactivated clear cell ovarian carcinoma. Nat Cancer. 2021;2(2):189\u2013200. https:\/\/doi.org\/10.1038\/s43018-020-00160-x.","journal-title":"Nat Cancer"},{"issue":"8","key":"2018_CR110","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1007\/s00204-020-02838-8","volume":"94","author":"JM Mat\u00e9s","year":"2020","unstructured":"Mat\u00e9s JM, Campos-Sandoval JA, de Santos-Jim\u00e9nez J, M\u00e1rquez J. Glutaminases regulate glutathione and oxidative stress in cancer. Arch Toxicol. 2020;94(8):2603\u201323. https:\/\/doi.org\/10.1007\/s00204-020-02838-8.","journal-title":"Arch Toxicol"},{"key":"2018_CR111","doi-asserted-by":"publisher","first-page":"106490","DOI":"10.1016\/j.phrs.2022.106490","volume":"185","author":"Q Wang","year":"2022","unstructured":"Wang Q, et al. Therapeutic targeting of glutamate dehydrogenase 1 that links metabolic reprogramming and Snail-mediated epithelial-mesenchymal transition in drug-resistant lung cancer. Pharmacol Res. 2022;185:106490. https:\/\/doi.org\/10.1016\/j.phrs.2022.106490.","journal-title":"Pharmacol Res"},{"issue":"12","key":"2018_CR112","doi-asserted-by":"publisher","first-page":"2578","DOI":"10.1002\/ijc.31274","volume":"142","author":"H Ma","year":"2018","unstructured":"Ma H, et al. Inhibition of SLC1A5 sensitizes colorectal cancer to cetuximab. Int J Cancer. 2018;142(12):2578\u201388. https:\/\/doi.org\/10.1002\/ijc.31274.","journal-title":"Int J Cancer"},{"key":"2018_CR113","doi-asserted-by":"publisher","first-page":"153473542110453","DOI":"10.1177\/15347354211045349","volume":"20","author":"H Ma","year":"2021","unstructured":"Ma H, et al. Inhibition of glutamine uptake improves the efficacy of cetuximab on gastric cancer. Integr Cancer Ther. 2021;20:15347354211045348. https:\/\/doi.org\/10.1177\/15347354211045349.","journal-title":"Integr Cancer Ther"},{"key":"2018_CR114","doi-asserted-by":"publisher","unstructured":"Polet F, Martherus R, Corbet C, Pinto A, Feron O. Inhibition of glucose metabolism prevents glycosylation of the glutamine transporter ASCT2 and promotes compensatory LAT1 upregulation in leukemia cells. Oncotarget. 2016;7(29):46371\u201383. https:\/\/doi.org\/10.18632\/oncotarget.10131.","DOI":"10.18632\/oncotarget.10131"},{"issue":"4","key":"2018_CR115","doi-asserted-by":"publisher","first-page":"101753","DOI":"10.1016\/j.jbc.2022.101753","volume":"298","author":"Q Li","year":"2022","unstructured":"Li Q, et al. Inhibitor of glutamine metabolism V9302 promotes ROS-induced autophagic degradation of B7H3 to enhance antitumor immunity. J Biol Chem. 2022;298(4):101753. https:\/\/doi.org\/10.1016\/j.jbc.2022.101753.","journal-title":"J Biol Chem"},{"issue":"7858","key":"2018_CR116","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1038\/s41586-021-03442-1","volume":"593","author":"BI Reinfeld","year":"2021","unstructured":"Reinfeld BI, et al. Cell-programmed nutrient partitioning in the tumour microenvironment. Nature. 2021;593(7858):282\u20138. https:\/\/doi.org\/10.1038\/s41586-021-03442-1.","journal-title":"Nature"},{"issue":"9","key":"2018_CR117","doi-asserted-by":"publisher","first-page":"2151","DOI":"10.3390\/cancers14092151","volume":"14","author":"I B\u00f6hme-Sch\u00e4fer","year":"2022","unstructured":"B\u00f6hme-Sch\u00e4fer I, L\u00f6rentz S, Bosserhoff AK. Role of Amino Acid Transporter SNAT1\/SLC38A1 in Human Melanoma. Cancers (Basel). 2022;14(9):2151. https:\/\/doi.org\/10.3390\/cancers14092151.","journal-title":"Cancers (Basel)"},{"issue":"25","key":"2018_CR118","doi-asserted-by":"publisher","first-page":"13194","DOI":"10.1074\/jbc.M115.700534","volume":"291","author":"A Br\u00f6er","year":"2016","unstructured":"Br\u00f6er A, Rahimi F, Br\u00f6er S. Deletion of Amino Acid Transporter ASCT2 (SLC1A5) Reveals an Essential Role for Transporters SNAT1 (SLC38A1) and SNAT2 (SLC38A2) to Sustain Glutaminolysis in Cancer Cells. J Biol Chem. 2016;291(25):13194\u2013205. https:\/\/doi.org\/10.1074\/jbc.M115.700534.","journal-title":"J Biol Chem"},{"issue":"11","key":"2018_CR119","doi-asserted-by":"publisher","first-page":"3051","DOI":"10.1016\/j.celrep.2019.02.037","volume":"26","author":"XH Lowman","year":"2019","unstructured":"Lowman XH, et al. p53 promotes cancer cell adaptation to glutamine deprivation by upregulating Slc7a3 to increase arginine uptake. Cell Rep. 2019;26(11):3051-3060.e4. https:\/\/doi.org\/10.1016\/j.celrep.2019.02.037.","journal-title":"Cell Rep"},{"issue":"19","key":"2018_CR120","doi-asserted-by":"publisher","first-page":"21836","DOI":"10.1021\/acsami.2c00111","volume":"14","author":"Y Xu","year":"2022","unstructured":"Xu Y, Yu Z, Fu H, Guo Y, Hu P, Shi J. Dual Inhibitions on Glucose\/Glutamine Metabolisms for Nontoxic Pancreatic Cancer Therapy. ACS Appl Mater Interfaces. 2022;14(19):21836\u201347. https:\/\/doi.org\/10.1021\/acsami.2c00111.","journal-title":"ACS Appl Mater Interfaces"},{"key":"2018_CR121","doi-asserted-by":"publisher","first-page":"101508","DOI":"10.1016\/j.tice.2021.101508","volume":"71","author":"L-B Li","year":"2021","unstructured":"Li L-B, Fang T-Y, Xu W-J. Oral glutamine inhibits tumor growth of gastric cancer bearing mice by improving immune function and activating apoptosis pathway. Tissue Cell. 2021;71:101508. https:\/\/doi.org\/10.1016\/j.tice.2021.101508.","journal-title":"Tissue Cell"},{"issue":"1","key":"2018_CR122","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1006\/jsre.1996.0263","volume":"63","author":"VS Klimberg","year":"1996","unstructured":"Klimberg VS, Kornbluth J, Cao Y, Dang A, Blossom S, Schaeffer RF. Glutamine suppresses PGE2 synthesis and breast cancer growth. J Surg Res. 1996;63(1):293\u20137. https:\/\/doi.org\/10.1006\/jsre.1996.0263.","journal-title":"J Surg Res"},{"issue":"6","key":"2018_CR123","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1111\/andr.134","volume":"2","author":"JL Medeiros","year":"2014","unstructured":"Medeiros JL, Costa WS, Felix-Patricio B, Sampaio FJB, Cardoso LEM. Protective effects of nutritional supplementation with arginine and glutamine on the penis of rats submitted to pelvic radiation. Andrology. 2014;2(6):943\u201350. https:\/\/doi.org\/10.1111\/andr.134.","journal-title":"Andrology"},{"key":"2018_CR124","doi-asserted-by":"publisher","first-page":"8832996","DOI":"10.1155\/2021\/8832996","volume":"2021","author":"C Hou","year":"2021","unstructured":"Hou C, et al. Metabolomic Study on the Therapeutic Effect of the Jianpi Yangzheng Xiaozheng Decoction on Gastric Cancer Treated with Chemotherapy Based on GC-TOFMS Analysis. Evid Based Complement Alternat Med. 2021;2021:8832996. https:\/\/doi.org\/10.1155\/2021\/8832996.","journal-title":"Evid Based Complement Alternat Med"},{"issue":"Suppl 1","key":"2018_CR125","first-page":"253","volume":"16","author":"Y Zheng","year":"2007","unstructured":"Zheng Y, et al. Application of perioperative immunonutrition for gastrointestinal surgery: a meta-analysis of randomized controlled trials. Asia Pac J Clin Nutr. 2007;16(Suppl 1):253\u20137.","journal-title":"Asia Pac J Clin Nutr"},{"issue":"2","key":"2018_CR126","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/s1015-9584(09)60275-x","volume":"28","author":"DW Chen","year":"2005","unstructured":"Chen DW, Wei Fei Z, Zhang YC, Ou JM, Xu J. Role of enteral immunonutrition in patients with gastric carcinoma undergoing major surgery. Asian J Surg. 2005;28(2):121\u20134. https:\/\/doi.org\/10.1016\/s1015-9584(09)60275-x.","journal-title":"Asian J Surg"},{"issue":"8","key":"2018_CR127","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1111\/j.1751-2980.2012.00596.x","volume":"13","author":"H Liu","year":"2012","unstructured":"Liu H, Ling W, Shen ZY, Jin X, Cao H. Clinical application of immune-enhanced enteral nutrition in patients with advanced gastric cancer after total gastrectomy. J Dig Dis. 2012;13(8):401\u20136. https:\/\/doi.org\/10.1111\/j.1751-2980.2012.00596.x.","journal-title":"J Dig Dis"},{"issue":"7\u20138","key":"2018_CR128","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1016\/j.nut.2010.07.020","volume":"27","author":"BR Rocha","year":"2011","unstructured":"Rocha BR, Gombar FM, Barcellos LM, Costa WS, Barcellos Sampaio FJ, Ramos CF. Glutamine supplementation prevents collagen expression damage in healthy urinary bladder caused by radiotherapy. Nutrition. 2011;27(7\u20138):809\u201315. https:\/\/doi.org\/10.1016\/j.nut.2010.07.020.","journal-title":"Nutrition"},{"issue":"5","key":"2018_CR129","first-page":"793","volume":"25","author":"O Izaola","year":"2010","unstructured":"Izaola O, et al. Influence of an immuno-enhanced formula in postsurgical ambulatory patients with head and neck cancer. Nutr Hosp. 2010;25(5):793\u20136.","journal-title":"Nutr Hosp"},{"issue":"5","key":"2018_CR130","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1080\/01635581.2016.1159700","volume":"68","author":"HWC Leung","year":"2016","unstructured":"Leung HWC, Chan ALF. Glutamine in alleviation of radiation-induced severe oral mucositis: a meta-analysis. Nutr Cancer. 2016;68(5):734\u201342. https:\/\/doi.org\/10.1080\/01635581.2016.1159700.","journal-title":"Nutr Cancer"},{"issue":"4","key":"2018_CR131","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1097\/00000658-199804000-00006","volume":"227","author":"S Yoshida","year":"1998","unstructured":"Yoshida S, Matsui M, Shirouzu Y, Fujita H, Yamana H, Shirouzu K. Effects of glutamine supplements and radiochemotherapy on systemic immune and gut barrier function in patients with advanced esophageal cancer. Ann Surg. 1998;227(4):485\u201391. https:\/\/doi.org\/10.1097\/00000658-199804000-00006.","journal-title":"Ann Surg"},{"issue":"3","key":"2018_CR132","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3390\/medicina58030394","volume":"58","author":"NM Sabry","year":"2022","unstructured":"Sabry NM, Naguib TM, Kabel AM, Khafagy E-S, Arab HH, Almorsy WA. Ameliorative Potential of L-Alanyl L-Glutamine Dipeptide in Colon Cancer Patients Receiving Modified FOLFOX-6 regarding the incidence of diarrhea, the treatment response, and patients\u2019 survival: a randomized controlled trial. Medicina (Kaunas). 2022;58(3):394. https:\/\/doi.org\/10.3390\/medicina58030394.","journal-title":"Medicina (Kaunas)"},{"issue":"1","key":"2018_CR133","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1111\/nmo.12702","volume":"28","author":"L Fracaro","year":"2016","unstructured":"Fracaro L, et al. Walker 256 tumor-bearing rats demonstrate altered interstitial cells of Cajal. Effects on ICC in the Walker 256 tumor model. Neurogastroenterol Motil. 2016;28(1):101\u201315. https:\/\/doi.org\/10.1111\/nmo.12702.","journal-title":"Neurogastroenterol Motil"},{"issue":"9","key":"2018_CR134","doi-asserted-by":"publisher","first-page":"e0162998","DOI":"10.1371\/journal.pone.0162998","volume":"11","author":"GE Vicentini","year":"2016","unstructured":"Vicentini GE, Fracaro L, de Souza SRG, Martins HA, Guarnier FA, Zanoni JN. Experimental Cancer Cachexia Changes Neuron Numbers and Peptide Levels in the Intestine: Partial Protective Effects after Dietary Supplementation with L-Glutamine. PLoS One. 2016;11(9):e0162998. https:\/\/doi.org\/10.1371\/journal.pone.0162998.","journal-title":"PLoS One"},{"issue":"1","key":"2018_CR135","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1097\/00000441-199801000-00002","volume":"315","author":"TR Ziegler","year":"1998","unstructured":"Ziegler TR, Bye RL, Persinger RL, Young LS, Antin JH, Wilmore DW. Effects of glutamine supplementation on circulating lymphocytes after bone marrow transplantation: a pilot study. Am J Med Sci. 1998;315(1):4\u201310. https:\/\/doi.org\/10.1097\/00000441-199801000-00002.","journal-title":"Am J Med Sci"},{"issue":"4","key":"2018_CR136","first-page":"328","volume":"8","author":"R Chen","year":"2005","unstructured":"Chen R, Cai J, Zhou B, Jiang A. Effect of immune-enhanced enteral diet on postoperative immunological function in patients with colorectal cancer. Zhonghua Wei Chang Wai Ke Za Zhi. 2005;8(4):328\u201330.","journal-title":"Zhonghua Wei Chang Wai Ke Za Zhi"},{"issue":"2","key":"2018_CR137","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1177\/0148607113478191","volume":"38","author":"A Vidal-Casariego","year":"2014","unstructured":"Vidal-Casariego A, Calleja-Fern\u00e1ndez A, de Urbina-Gonz\u00e1lez JJO, Cano-Rodr\u00edguez I, Cordido F, Ballesteros-Pomar MD. Efficacy of glutamine in the prevention of acute radiation enteritis: a randomized controlled trial. JPEN J Parenter Enteral Nutr. 2014;38(2):205\u201313. https:\/\/doi.org\/10.1177\/0148607113478191.","journal-title":"JPEN J Parenter Enteral Nutr"},{"issue":"4","key":"2018_CR138","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s005200000178","volume":"9","author":"H K\u00f6hler","year":"2001","unstructured":"K\u00f6hler H, Klowik M, Brand O, G\u00f6bel U, Schroten H. Influence of glutamine and glycyl-glutamine on in vitro lymphocyte proliferation in children with solid tumors. Support Care Cancer. 2001;9(4):261\u20136. https:\/\/doi.org\/10.1007\/s005200000178.","journal-title":"Support Care Cancer"}],"container-title":["Cell Communication and Signaling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-024-02018-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12964-024-02018-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-024-02018-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T00:11:28Z","timestamp":1737677488000},"score":1,"resource":{"primary":{"URL":"https:\/\/biosignaling.biomedcentral.com\/articles\/10.1186\/s12964-024-02018-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,24]]},"references-count":138,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2018"],"URL":"https:\/\/doi.org\/10.1186\/s12964-024-02018-6","relation":{},"ISSN":["1478-811X"],"issn-type":[{"value":"1478-811X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,24]]},"assertion":[{"value":"30 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"45"}}